A Behavioral Intervention To Improve Hypertension Control In Veterans
8 mei 2015 bijgewerkt door: US Department of Veterans Affairs
A Behavioral Intervention to Improve Hypertension Control in Veterans
The purpose of this study is to determine whether a stage-matched intervention (SMI) will lower BP and improve treatment adherence compared to usual care (UC) or a health education intervention (HEI) in veterans with uncontrolled BP.
The study will also examine the effect of SMI on patient's health-related quality of life, satisfaction, acceptability and determine its cost-effectiveness.
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
We propose a randomized controlled trial to evaluate the effect of telephone-delivered interventions (SMI and HEI) to improve BP control.
Veterans with uncontrolled hypertension (n=533) will be randomized equally to 3 groups: 1) The SMI will use the Transtheoretical model (TTM) as the unifying framework. Veterans will receive TTM stage-matched counseling for exercise, diet, and medications via monthly counseling sessions. A social worker (SW) will assess each participant's behavior and deliver the appropriate tailored SMI based on their stage of change, decisional balance, self-efficacy and the skills model questions. 2) The HEI group receives monthly telephone calls by a SW during which they will receive education about hypertension management. 3) The UC group participates in all the in-person visits but does not receive monthly calls.
There will be an initial 6-month active intervention phase followed by a 6 month monitoring phase to assess sustainability. All participants will visit the VAMC's at baseline and at 3, 6, and 12 months. Outcomes of interest include BP; adherence (to diet, exercise and medications); quality of life; satisfaction; acceptability; cost and cost-effectiveness. Patients will be blinded to which of the intervention arms (SMI or HEI) they are in, SW's will be blinded to patient's BP and staff measuring outcomes will be blinded to study assignment. The study will be analyzed using longitudinal data analysis methods using an intention to treat strategy.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
533
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
New York
-
New York, New York, Verenigde Staten, 10010
- VA New York Harbor Health Care System
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
21 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Patients receiving continuity of care in the outpatient clinics will be eligible. This will be operationalized as 2 visits in the previous year.
- Adults (= 21 years) with hypertension, on antihypertensive medication for = 1 year, and who have current uncontrolled BP will be enrolled.
Patients with CVD:
- chronic stable angina
- unstable angina
- uncomplicated myocardial infarction
- coronary artery bypass surgery
- percutaneous coronary angioplasty
- atherectomy or stent placement
- chronic stable angina pectoris
- stable Class I or Class II congestive heart failure
- stroke
- peripheral vascular disease
will be entered into the study if the CVD event or diagnosis occurred = 6 months ago.
Exclusion Criteria:
Patients with limited life expectancy (< 1 year) due to severe co-existing non-CVD disease such as:
- terminal illnesses such as terminal cancer
- CVD < 6 months ago
- Class III or IV CHF
- severe psychiatric illness such as psychosis
- manic depression
- alcohol abuse (> 21 drinks/week)
- serious chronic conditions like AIDS
- tuberculosis
- lupus
- and end-stage renal failure
will be excluded.
- Other exclusions include inability to understand English
- Lack of a landline telephone
- Unable to follow the study protocol
- Recent major surgery (< 3 months)
- Patients who are temporarily in the area and plan to move in < 1 year or will not be available for follow-up
- Those unable to provide informed consent.
- All patients excluded and reason for exclusion will be recorded.
- Prior to recruitment, each patient will be informed about the study and informed consent obtained.
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Stage-matched intervention (SMI)
|
Stage-matched intervention
Health Education Intervention
Usual Care
|
|
Actieve vergelijker: Health Education Intervention (HEI)
|
Stage-matched intervention
Health Education Intervention
Usual Care
|
|
Geen tussenkomst: Usual Care (UC)
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Blood Pressure Control
Tijdsspanne: 6 months
|
Blood pressure Control at 6 months
|
6 months
|
|
Systolic Blood Pressure
Tijdsspanne: 6 months
|
Mean systolic Blood Pressure
|
6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Proportion With BP Under Control From Baseline to 6 Months
Tijdsspanne: 6 months
|
6 months
|
|
|
Change in Systolic Blood Pressure From Baseline to 6 Months
Tijdsspanne: Baseline and 6 months
|
Baseline and 6 months
|
|
|
Change in Number of Cardio Exercise Hours From Baseline to 6 Months
Tijdsspanne: baseline and 6 months
|
baseline and 6 months
|
|
|
Change in Morisky Score From Baseline to 6 Months
Tijdsspanne: baseline and 6 months
|
Morkisy medication adherence self-report questionnaire, a 4-item questionnaire scored from 0-4.
A score of 4 is considered most adherent, and scores of less than 4 are defined as nonadherent
|
baseline and 6 months
|
|
Diet Stage of Change
Tijdsspanne: 6 months
|
The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months.
Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.
|
6 months
|
|
Exercise Stage of Change
Tijdsspanne: 6 months
|
The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months.
Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time.
We used the lower threshold for exercise adherence due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.
|
6 months
|
|
Medication Stage of Change
Tijdsspanne: 6 months
|
The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months.
Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.
|
6 months
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Onderzoekers
- Hoofdonderzoeker: Sundar Natarajan, MD MSc, VA New York Harbor Health Care System
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Algemene publicaties
- Ulmer M, Robinaugh D, Friedberg JP, Lipsitz SR, Natarajan S. Usefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral intervention. Contemp Clin Trials. 2008 Sep;29(5):705-10. doi: 10.1016/j.cct.2008.04.005. Epub 2008 May 6.
- Friedberg JP, Lipsitz SR, Natarajan S. Challenges and recommendations for blinding in behavioral interventions illustrated using a case study of a behavioral intervention to lower blood pressure. Patient Educ Couns. 2010 Jan;78(1):5-11. doi: 10.1016/j.pec.2009.04.009. Epub 2009 Jun 13.
- Friedberg JP, Rodriguez MA, Watsula ME, Lin I, Wylie-Rosett J, Allegrante JP, Lipsitz SR, Natarajan S. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015 Feb;65(2):440-6. doi: 10.1161/HYPERTENSIONAHA.114.03483. Epub 2014 Nov 17.
- Rodriguez MA, Wang B, Hyoung S, Friedberg J, Wylie-Rosett J, Fang Y, Allegrante JP, Lipsitz SR, Natarajan S. Sustained Benefit of Alternate Behavioral Interventions to Improve Hypertension Control: A Randomized Clinical Trial. Hypertension. 2021 Jun;77(6):1867-1876. doi: 10.1161/HYPERTENSIONAHA.120.15192. Epub 2021 May 12.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start
1 juli 2006
Primaire voltooiing (Werkelijk)
1 januari 2010
Studie voltooiing (Werkelijk)
1 september 2011
Studieregistratiedata
Eerst ingediend
1 februari 2006
Eerst ingediend dat voldeed aan de QC-criteria
1 februari 2006
Eerst geplaatst (Schatting)
3 februari 2006
Updates van studierecords
Laatste update geplaatst (Schatting)
1 juni 2015
Laatste update ingediend die voldeed aan QC-criteria
8 mei 2015
Laatst geverifieerd
1 mei 2015
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- IIR 04-170
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op SMI
-
VA Office of Research and DevelopmentVoltooidPsychotische stoornissen | Obesitas | GezondheidsgedragVerenigde Staten
-
Medical University of South CarolinaNational Institute of Nursing Research (NINR)VoltooidVermoeidheid | Hiv | Stressstoornis | Humaan Immunodeficiëntie VirusVerenigde Staten
-
Sofregen Medical, Inc.Symbio, LLCVoltooidNasolabiale plooi | WangvergrotingVerenigde Staten
-
Second Affiliated Hospital, School of Medicine,...Onbekend
-
University Hospital, ToulouseOnbekendMastocytose | CutaanFrankrijk
-
Vrije Universiteit BrusselNog niet aan het werven
-
Nigde Omer Halisdemir UniversityVoltooidOntsteking | Syndroom van Sjogren | Klier; OntstekingKalkoen
-
Uşak UniversityVoltooidCarpaal Tunnel Syndroom BilateraalKalkoen
-
Nigde Omer Halisdemir UniversityVoltooidFasciitis plantaris | Diagnose van ziekteKalkoen
-
VA Office of Research and DevelopmentVoltooidSchizofreniespectrum en andere psychotische stoornissenVerenigde Staten